News
EOS imaging Reports Its Full Year 2019 Sales
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
BIOCORP und SANOFI erweitern ihre Partnerschaft mit Mallya Smart Sensors
Pflichtmitteilung:
BIOCORP (Paris:ALCOR) (FR0012788065 – ALCOR / Eligible PEA PME), ein französisches Unternehmen, das sich auf die Entwicklung und Herstellung von medizinischen Geräten und
MEDICREA Announces Preliminary Discussions With U.S. Strategic Partners
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling
Mauna Kea Technologies Announces Publication of Positive Results on Needle-Based Endomicroscopy for the Clinical Management of Pancreatic Cystic Lesions
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) inventor of Cellvizio®, the multidisciplinary probe- and needle-based confocal laser endomicroscopy (pCLE/nCLE) platform, today
MEDICREA® Secures 7 New US Patents Around Its Proprietary Platform Technology UNiD™ ASI And Reinforces Barriers to Entry for Competitors
The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX
Best Market –MRNTF), pioneering the transformation of spinal surgery
through Artificial Intelligence,
EOS imaging Announces Its Financial Agenda For 2020
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
Mauna Kea Technologies Announces Strategic Equity Investment of €7.5 Million by Johnson & Johnson Innovation
Regulatory News:
Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE)
BIOCORP und SANOFI kooperieren bei der weltweiten Ausstattung des Insulinpens SoloStar mit Mallya-Technologie
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), ein französisches Unternehmen mit Spezialisierung in der Entwicklung und Herstellung von Medizinprodukten und intelligenten Systemen
BIOCORP and SANOFI Announce a Partnership to Fit SoloStar Insulin Pens With Mallya Technology Worldwide
Regulatory News:
BIOCORP (Paris:ALCOR) (FR0012788065 - ALCOR / Eligible PEA PME), a French company specializing in the development and manufacturing of medical devices and smart drug delivery
EOS imaging RECEIVES U.S. FDA 510(K) CLEARANCE FOR EOSedge™ ITS NEW GENERATION INNOVATIVE IMAGING SYSTEM
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005574/en/
EOSedge™ (Photo: Business Wire)
EOS imaging
EOS imaging Announces the Upcoming Launch of EOSedge™, Its New Generation Imaging System
Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191126005639/en/
(Photo: Business Wire)
EOS imaging (Paris:EOSI)
Medicrea Reports Third Quarter 2019 Financial Results
The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the digital transformation of spinal surgery through artificial Intelligence, predictive
EOS imaging Announces 350th System Worldwide Installed at University of Missouri Health Care
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and
EOS imaging to Present Advanced Orthopedic Solutions at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting 2019
Regulatory News:
EOS imaging (Paris:EOSI) (Euronext, FR0011191766 - EOSI - Eligible PEA - PME), a leader in 2D/3D orthopedic medical imaging and software solutions for 3D anatomical modeling and